nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIK1—Parkinson's disease	0.546	0.776	CbGaD
Topiramate—GRIK2—Parkinson's disease	0.157	0.223	CbGaD
Topiramate—GRIA4—cerebellar cortex—Parkinson's disease	0.00815	0.0672	CbGeAlD
Topiramate—GRIK1—cerebellar cortex—Parkinson's disease	0.00714	0.0589	CbGeAlD
Topiramate—GRIK1—telencephalic ventricle—Parkinson's disease	0.00415	0.0343	CbGeAlD
Topiramate—GRIA1—cerebellar cortex—Parkinson's disease	0.00355	0.0293	CbGeAlD
Topiramate—GRIK1—peripheral nervous system—Parkinson's disease	0.00336	0.0277	CbGeAlD
Topiramate—GRIA4—nerve—Parkinson's disease	0.00299	0.0246	CbGeAlD
Topiramate—GRIK1—nerve—Parkinson's disease	0.00262	0.0216	CbGeAlD
Topiramate—GRIK2—cerebellar cortex—Parkinson's disease	0.00254	0.021	CbGeAlD
Topiramate—GRIA3—nerve—Parkinson's disease	0.00243	0.0201	CbGeAlD
Topiramate—GRIA4—hindbrain—Parkinson's disease	0.00224	0.0185	CbGeAlD
Topiramate—GRIK5—hindbrain—Parkinson's disease	0.00206	0.017	CbGeAlD
Topiramate—GRIA1—telencephalic ventricle—Parkinson's disease	0.00206	0.017	CbGeAlD
Topiramate—GRIK1—hindbrain—Parkinson's disease	0.00196	0.0162	CbGeAlD
Topiramate—GRIK4—forebrain—Parkinson's disease	0.00157	0.0129	CbGeAlD
Topiramate—GRIK2—telencephalic ventricle—Parkinson's disease	0.00148	0.0122	CbGeAlD
Topiramate—GRIA1—nerve—Parkinson's disease	0.0013	0.0107	CbGeAlD
Topiramate—GRIA4—brainstem—Parkinson's disease	0.00128	0.0106	CbGeAlD
Topiramate—GRIA4—forebrain—Parkinson's disease	0.00124	0.0102	CbGeAlD
Topiramate—GRIK5—brainstem—Parkinson's disease	0.00118	0.00977	CbGeAlD
Topiramate—GRIK5—forebrain—Parkinson's disease	0.00114	0.00942	CbGeAlD
Topiramate—GRIK3—forebrain—Parkinson's disease	0.00114	0.00942	CbGeAlD
Topiramate—GRIK1—brainstem—Parkinson's disease	0.00112	0.00928	CbGeAlD
Topiramate—GRIK1—forebrain—Parkinson's disease	0.00108	0.00895	CbGeAlD
Topiramate—GRIA3—forebrain—Parkinson's disease	0.00101	0.00832	CbGeAlD
Topiramate—GRIA1—hindbrain—Parkinson's disease	0.000974	0.00804	CbGeAlD
Topiramate—GRIK2—nerve—Parkinson's disease	0.000933	0.0077	CbGeAlD
Topiramate—GRIK4—head—Parkinson's disease	0.000896	0.0074	CbGeAlD
Topiramate—GRIA4—medulla oblongata—Parkinson's disease	0.000894	0.00738	CbGeAlD
Topiramate—GRIK4—nervous system—Parkinson's disease	0.00085	0.00701	CbGeAlD
Topiramate—GRIK3—medulla oblongata—Parkinson's disease	0.000825	0.00681	CbGeAlD
Topiramate—GRIK5—medulla oblongata—Parkinson's disease	0.000825	0.00681	CbGeAlD
Topiramate—GRIK4—central nervous system—Parkinson's disease	0.000818	0.00675	CbGeAlD
Topiramate—GRIK4—cerebellum—Parkinson's disease	0.0008	0.0066	CbGeAlD
Topiramate—GRIA4—spinal cord—Parkinson's disease	0.000797	0.00658	CbGeAlD
Topiramate—GRIK1—medulla oblongata—Parkinson's disease	0.000784	0.00647	CbGeAlD
Topiramate—GRIA2—hindbrain—Parkinson's disease	0.000773	0.00638	CbGeAlD
Topiramate—GRIK5—midbrain—Parkinson's disease	0.000754	0.00622	CbGeAlD
Topiramate—GRIK3—midbrain—Parkinson's disease	0.000754	0.00622	CbGeAlD
Topiramate—GRIK3—spinal cord—Parkinson's disease	0.000736	0.00607	CbGeAlD
Topiramate—GRIK5—spinal cord—Parkinson's disease	0.000736	0.00607	CbGeAlD
Topiramate—GRIA3—medulla oblongata—Parkinson's disease	0.000729	0.00601	CbGeAlD
Topiramate—GRIK1—midbrain—Parkinson's disease	0.000716	0.00591	CbGeAlD
Topiramate—GRIA4—head—Parkinson's disease	0.000708	0.00585	CbGeAlD
Topiramate—SCN1A—hindbrain—Parkinson's disease	0.000706	0.00582	CbGeAlD
Topiramate—GRIK1—spinal cord—Parkinson's disease	0.000699	0.00577	CbGeAlD
Topiramate—GRIK2—hindbrain—Parkinson's disease	0.000699	0.00577	CbGeAlD
Topiramate—CA1—nerve—Parkinson's disease	0.000691	0.0057	CbGeAlD
Topiramate—GRIA4—nervous system—Parkinson's disease	0.000672	0.00554	CbGeAlD
Topiramate—GRIA3—midbrain—Parkinson's disease	0.000666	0.0055	CbGeAlD
Topiramate—GRIK3—head—Parkinson's disease	0.000654	0.0054	CbGeAlD
Topiramate—GRIK5—head—Parkinson's disease	0.000654	0.0054	CbGeAlD
Topiramate—GRIA3—spinal cord—Parkinson's disease	0.00065	0.00536	CbGeAlD
Topiramate—GRIK4—brain—Parkinson's disease	0.000649	0.00536	CbGeAlD
Topiramate—GRIA4—central nervous system—Parkinson's disease	0.000647	0.00534	CbGeAlD
Topiramate—GRIA4—cerebellum—Parkinson's disease	0.000632	0.00522	CbGeAlD
Topiramate—GRIK1—head—Parkinson's disease	0.000621	0.00513	CbGeAlD
Topiramate—GRIK3—nervous system—Parkinson's disease	0.00062	0.00512	CbGeAlD
Topiramate—GRIK5—nervous system—Parkinson's disease	0.00062	0.00512	CbGeAlD
Topiramate—GRIK5—central nervous system—Parkinson's disease	0.000597	0.00493	CbGeAlD
Topiramate—GRIK3—central nervous system—Parkinson's disease	0.000597	0.00493	CbGeAlD
Topiramate—GRIK1—nervous system—Parkinson's disease	0.000589	0.00486	CbGeAlD
Topiramate—GRIK5—cerebellum—Parkinson's disease	0.000583	0.00481	CbGeAlD
Topiramate—GRIK3—cerebellum—Parkinson's disease	0.000583	0.00481	CbGeAlD
Topiramate—GRIA3—head—Parkinson's disease	0.000578	0.00477	CbGeAlD
Topiramate—GRIK1—central nervous system—Parkinson's disease	0.000567	0.00468	CbGeAlD
Topiramate—GRIA1—brainstem—Parkinson's disease	0.000558	0.00461	CbGeAlD
Topiramate—GRIK1—cerebellum—Parkinson's disease	0.000554	0.00457	CbGeAlD
Topiramate—GABRB2—hindbrain—Parkinson's disease	0.00055	0.00454	CbGeAlD
Topiramate—GRIA3—nervous system—Parkinson's disease	0.000548	0.00452	CbGeAlD
Topiramate—CA4—nerve—Parkinson's disease	0.00054	0.00446	CbGeAlD
Topiramate—GRIA1—forebrain—Parkinson's disease	0.000539	0.00445	CbGeAlD
Topiramate—GRIA3—central nervous system—Parkinson's disease	0.000527	0.00435	CbGeAlD
Topiramate—GRIA3—cerebellum—Parkinson's disease	0.000515	0.00425	CbGeAlD
Topiramate—GRIA4—brain—Parkinson's disease	0.000513	0.00424	CbGeAlD
Topiramate—GABRA1—hindbrain—Parkinson's disease	0.000486	0.00401	CbGeAlD
Topiramate—GRIA2—embryo—Parkinson's disease	0.000484	0.00399	CbGeAlD
Topiramate—GRIK3—brain—Parkinson's disease	0.000474	0.00391	CbGeAlD
Topiramate—GRIK5—brain—Parkinson's disease	0.000474	0.00391	CbGeAlD
Topiramate—GRIK1—brain—Parkinson's disease	0.00045	0.00372	CbGeAlD
Topiramate—GRIA2—brainstem—Parkinson's disease	0.000443	0.00366	CbGeAlD
Topiramate—GRIA2—forebrain—Parkinson's disease	0.000428	0.00353	CbGeAlD
Topiramate—GRIA3—brain—Parkinson's disease	0.000419	0.00345	CbGeAlD
Topiramate—SCN1A—brainstem—Parkinson's disease	0.000404	0.00334	CbGeAlD
Topiramate—CA4—hindbrain—Parkinson's disease	0.000404	0.00334	CbGeAlD
Topiramate—GRIK2—brainstem—Parkinson's disease	0.0004	0.00331	CbGeAlD
Topiramate—SCN1A—forebrain—Parkinson's disease	0.00039	0.00322	CbGeAlD
Topiramate—GRIA1—medulla oblongata—Parkinson's disease	0.000389	0.00321	CbGeAlD
Topiramate—GRIK2—forebrain—Parkinson's disease	0.000387	0.00319	CbGeAlD
Topiramate—CA7—midbrain—Parkinson's disease	0.000367	0.00303	CbGeAlD
Topiramate—CA12—forebrain—Parkinson's disease	0.000361	0.00298	CbGeAlD
Topiramate—GRIA1—midbrain—Parkinson's disease	0.000356	0.00294	CbGeAlD
Topiramate—GRIA1—spinal cord—Parkinson's disease	0.000347	0.00286	CbGeAlD
Topiramate—CA2—hindbrain—Parkinson's disease	0.000335	0.00277	CbGeAlD
Topiramate—GABRB2—brainstem—Parkinson's disease	0.000315	0.0026	CbGeAlD
Topiramate—CA6—head—Parkinson's disease	0.000308	0.00255	CbGeAlD
Topiramate—GRIA1—head—Parkinson's disease	0.000308	0.00255	CbGeAlD
Topiramate—GABRB2—forebrain—Parkinson's disease	0.000304	0.00251	CbGeAlD
Topiramate—GABRG2—forebrain—Parkinson's disease	0.000304	0.00251	CbGeAlD
Topiramate—GRIA1—nervous system—Parkinson's disease	0.000292	0.00241	CbGeAlD
Topiramate—CA1—forebrain—Parkinson's disease	0.000286	0.00236	CbGeAlD
Topiramate—CA7—cerebellum—Parkinson's disease	0.000284	0.00234	CbGeAlD
Topiramate—GRIA2—midbrain—Parkinson's disease	0.000283	0.00233	CbGeAlD
Topiramate—SCN1A—medulla oblongata—Parkinson's disease	0.000282	0.00233	CbGeAlD
Topiramate—GRIA1—central nervous system—Parkinson's disease	0.000281	0.00232	CbGeAlD
Topiramate—GRIK2—medulla oblongata—Parkinson's disease	0.000279	0.0023	CbGeAlD
Topiramate—GABRA1—brainstem—Parkinson's disease	0.000278	0.0023	CbGeAlD
Topiramate—GRIA2—spinal cord—Parkinson's disease	0.000276	0.00228	CbGeAlD
Topiramate—GRIA1—cerebellum—Parkinson's disease	0.000275	0.00227	CbGeAlD
Topiramate—CA5B—cardiovascular system—Parkinson's disease	0.000274	0.00226	CbGeAlD
Topiramate—GABRA1—forebrain—Parkinson's disease	0.000269	0.00222	CbGeAlD
Topiramate—SCN5A—cardiovascular system—Parkinson's disease	0.000265	0.00219	CbGeAlD
Topiramate—SCN1A—midbrain—Parkinson's disease	0.000258	0.00213	CbGeAlD
Topiramate—GRIK2—midbrain—Parkinson's disease	0.000255	0.00211	CbGeAlD
Topiramate—SCN1A—spinal cord—Parkinson's disease	0.000251	0.00208	CbGeAlD
Topiramate—CA9—cerebellum—Parkinson's disease	0.000249	0.00206	CbGeAlD
Topiramate—GRIK2—spinal cord—Parkinson's disease	0.000249	0.00206	CbGeAlD
Topiramate—GRIA2—head—Parkinson's disease	0.000245	0.00202	CbGeAlD
Topiramate—CA1—cardiovascular system—Parkinson's disease	0.000242	0.002	CbGeAlD
Topiramate—GRIA2—nervous system—Parkinson's disease	0.000232	0.00192	CbGeAlD
Topiramate—CA4—brainstem—Parkinson's disease	0.000232	0.00191	CbGeAlD
Topiramate—CA7—brain—Parkinson's disease	0.000231	0.0019	CbGeAlD
Topiramate—CA4—forebrain—Parkinson's disease	0.000224	0.00185	CbGeAlD
Topiramate—GRIA2—central nervous system—Parkinson's disease	0.000224	0.00185	CbGeAlD
Topiramate—SCN1A—head—Parkinson's disease	0.000224	0.00184	CbGeAlD
Topiramate—GRIA1—brain—Parkinson's disease	0.000223	0.00184	CbGeAlD
Topiramate—GRIK2—head—Parkinson's disease	0.000221	0.00183	CbGeAlD
Topiramate—GABRB2—medulla oblongata—Parkinson's disease	0.00022	0.00181	CbGeAlD
Topiramate—GABRG2—medulla oblongata—Parkinson's disease	0.00022	0.00181	CbGeAlD
Topiramate—GRIA2—cerebellum—Parkinson's disease	0.000219	0.0018	CbGeAlD
Topiramate—SCN1A—nervous system—Parkinson's disease	0.000212	0.00175	CbGeAlD
Topiramate—GRIK2—nervous system—Parkinson's disease	0.00021	0.00173	CbGeAlD
Topiramate—CA2—embryo—Parkinson's disease	0.00021	0.00173	CbGeAlD
Topiramate—CA12—head—Parkinson's disease	0.000207	0.00171	CbGeAlD
Topiramate—SCN1A—central nervous system—Parkinson's disease	0.000204	0.00168	CbGeAlD
Topiramate—GRIK2—central nervous system—Parkinson's disease	0.000202	0.00167	CbGeAlD
Topiramate—GABRB2—midbrain—Parkinson's disease	0.000201	0.00166	CbGeAlD
Topiramate—GABRG2—midbrain—Parkinson's disease	0.000201	0.00166	CbGeAlD
Topiramate—SCN1A—cerebellum—Parkinson's disease	0.000199	0.00165	CbGeAlD
Topiramate—GRIK2—cerebellum—Parkinson's disease	0.000197	0.00163	CbGeAlD
Topiramate—CA12—nervous system—Parkinson's disease	0.000196	0.00162	CbGeAlD
Topiramate—GABRB2—spinal cord—Parkinson's disease	0.000196	0.00162	CbGeAlD
Topiramate—GABRG2—spinal cord—Parkinson's disease	0.000196	0.00162	CbGeAlD
Topiramate—GABRA1—medulla oblongata—Parkinson's disease	0.000194	0.0016	CbGeAlD
Topiramate—CA2—brainstem—Parkinson's disease	0.000192	0.00159	CbGeAlD
Topiramate—CA4—cardiovascular system—Parkinson's disease	0.000189	0.00156	CbGeAlD
Topiramate—CA12—central nervous system—Parkinson's disease	0.000189	0.00156	CbGeAlD
Topiramate—CA5B—head—Parkinson's disease	0.000186	0.00153	CbGeAlD
Topiramate—CA2—forebrain—Parkinson's disease	0.000185	0.00153	CbGeAlD
Topiramate—CA1—spinal cord—Parkinson's disease	0.000184	0.00152	CbGeAlD
Topiramate—SCN5A—head—Parkinson's disease	0.00018	0.00148	CbGeAlD
Topiramate—GRIA2—brain—Parkinson's disease	0.000178	0.00147	CbGeAlD
Topiramate—GABRA1—midbrain—Parkinson's disease	0.000177	0.00146	CbGeAlD
Topiramate—CA5B—nervous system—Parkinson's disease	0.000176	0.00145	CbGeAlD
Topiramate—GABRB2—head—Parkinson's disease	0.000174	0.00144	CbGeAlD
Topiramate—GABRG2—head—Parkinson's disease	0.000174	0.00144	CbGeAlD
Topiramate—GABRA1—spinal cord—Parkinson's disease	0.000173	0.00143	CbGeAlD
Topiramate—SCN5A—nervous system—Parkinson's disease	0.00017	0.00141	CbGeAlD
Topiramate—CA5B—central nervous system—Parkinson's disease	0.000169	0.0014	CbGeAlD
Topiramate—GABRB2—nervous system—Parkinson's disease	0.000165	0.00136	CbGeAlD
Topiramate—GABRG2—nervous system—Parkinson's disease	0.000165	0.00136	CbGeAlD
Topiramate—SCN5A—central nervous system—Parkinson's disease	0.000164	0.00135	CbGeAlD
Topiramate—CA1—head—Parkinson's disease	0.000164	0.00135	CbGeAlD
Topiramate—SCN1A—brain—Parkinson's disease	0.000162	0.00134	CbGeAlD
Topiramate—CA4—medulla oblongata—Parkinson's disease	0.000162	0.00133	CbGeAlD
Topiramate—GRIK2—brain—Parkinson's disease	0.00016	0.00132	CbGeAlD
Topiramate—GABRG2—central nervous system—Parkinson's disease	0.000159	0.00131	CbGeAlD
Topiramate—GABRB2—central nervous system—Parkinson's disease	0.000159	0.00131	CbGeAlD
Topiramate—CA2—cardiovascular system—Parkinson's disease	0.000157	0.00129	CbGeAlD
Topiramate—GABRB2—cerebellum—Parkinson's disease	0.000155	0.00128	CbGeAlD
Topiramate—GABRG2—cerebellum—Parkinson's disease	0.000155	0.00128	CbGeAlD
Topiramate—CA1—nervous system—Parkinson's disease	0.000155	0.00128	CbGeAlD
Topiramate—GABRA1—head—Parkinson's disease	0.000154	0.00127	CbGeAlD
Topiramate—CA12—brain—Parkinson's disease	0.00015	0.00124	CbGeAlD
Topiramate—CA1—central nervous system—Parkinson's disease	0.00015	0.00123	CbGeAlD
Topiramate—CA4—midbrain—Parkinson's disease	0.000148	0.00122	CbGeAlD
Topiramate—GABRA1—nervous system—Parkinson's disease	0.000146	0.0012	CbGeAlD
Topiramate—CA4—spinal cord—Parkinson's disease	0.000144	0.00119	CbGeAlD
Topiramate—GABRA1—central nervous system—Parkinson's disease	0.00014	0.00116	CbGeAlD
Topiramate—GABRA1—cerebellum—Parkinson's disease	0.000137	0.00113	CbGeAlD
Topiramate—CA5B—brain—Parkinson's disease	0.000134	0.00111	CbGeAlD
Topiramate—CA2—medulla oblongata—Parkinson's disease	0.000134	0.00111	CbGeAlD
Topiramate—SCN5A—brain—Parkinson's disease	0.00013	0.00108	CbGeAlD
Topiramate—CA4—head—Parkinson's disease	0.000128	0.00106	CbGeAlD
Topiramate—GABRB2—brain—Parkinson's disease	0.000126	0.00104	CbGeAlD
Topiramate—GABRG2—brain—Parkinson's disease	0.000126	0.00104	CbGeAlD
Topiramate—CA2—midbrain—Parkinson's disease	0.000122	0.00101	CbGeAlD
Topiramate—CA4—nervous system—Parkinson's disease	0.000121	0.001	CbGeAlD
Topiramate—CA2—spinal cord—Parkinson's disease	0.000119	0.000986	CbGeAlD
Topiramate—CA1—brain—Parkinson's disease	0.000119	0.00098	CbGeAlD
Topiramate—CA4—central nervous system—Parkinson's disease	0.000117	0.000965	CbGeAlD
Topiramate—CA4—cerebellum—Parkinson's disease	0.000114	0.000943	CbGeAlD
Topiramate—GABRA1—brain—Parkinson's disease	0.000111	0.00092	CbGeAlD
Topiramate—CA2—head—Parkinson's disease	0.000106	0.000876	CbGeAlD
Topiramate—CA2—nervous system—Parkinson's disease	0.000101	0.000831	CbGeAlD
Topiramate—CA2—central nervous system—Parkinson's disease	9.69e-05	0.0008	CbGeAlD
Topiramate—CA2—cerebellum—Parkinson's disease	9.47e-05	0.000782	CbGeAlD
Topiramate—CA4—brain—Parkinson's disease	9.28e-05	0.000766	CbGeAlD
Topiramate—CA2—brain—Parkinson's disease	7.69e-05	0.000635	CbGeAlD
Topiramate—CYP3A4—nervous system—Parkinson's disease	6.49e-05	0.000536	CbGeAlD
Topiramate—CYP3A4—central nervous system—Parkinson's disease	6.25e-05	0.000516	CbGeAlD
Topiramate—CA5A—Metabolism—CYCS—Parkinson's disease	1.57e-05	8.9e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYCS—Parkinson's disease	1.57e-05	8.9e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ABL1—Parkinson's disease	1.56e-05	8.89e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP2E1—Parkinson's disease	1.56e-05	8.88e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP2E1—Parkinson's disease	1.56e-05	8.88e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—MAOB—Parkinson's disease	1.56e-05	8.88e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—CTGF—Parkinson's disease	1.56e-05	8.83e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—NQO1—Parkinson's disease	1.55e-05	8.78e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NQO1—Parkinson's disease	1.55e-05	8.78e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTA4—Parkinson's disease	1.54e-05	8.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	1.53e-05	8.68e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TH—Parkinson's disease	1.52e-05	8.66e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—TH—Parkinson's disease	1.52e-05	8.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	1.52e-05	8.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	1.51e-05	8.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	1.5e-05	8.5e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	1.49e-05	8.44e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—INS—Parkinson's disease	1.47e-05	8.35e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYCS—Parkinson's disease	1.46e-05	8.31e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYCS—Parkinson's disease	1.46e-05	8.31e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP2E1—Parkinson's disease	1.45e-05	8.23e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—NQO1—Parkinson's disease	1.43e-05	8.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	1.42e-05	8.09e-05	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MAPK8—Parkinson's disease	1.41e-05	8.02e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—TH—Parkinson's disease	1.41e-05	8.02e-05	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	1.41e-05	8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	1.4e-05	7.94e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—COMT—Parkinson's disease	1.39e-05	7.89e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—COMT—Parkinson's disease	1.39e-05	7.89e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PLA2G6—Parkinson's disease	1.39e-05	7.88e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTP1—Parkinson's disease	1.38e-05	7.85e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTP1—Parkinson's disease	1.38e-05	7.85e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—MAOA—Parkinson's disease	1.38e-05	7.83e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MAOA—Parkinson's disease	1.38e-05	7.83e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MAOB—Parkinson's disease	1.37e-05	7.8e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—HMOX1—Parkinson's disease	1.36e-05	7.74e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HMOX1—Parkinson's disease	1.36e-05	7.74e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYCS—Parkinson's disease	1.36e-05	7.7e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	1.35e-05	7.68e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.32e-05	7.52e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCB1—Parkinson's disease	1.31e-05	7.43e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCB1—Parkinson's disease	1.31e-05	7.43e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—COMT—Parkinson's disease	1.3e-05	7.36e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—COMT—Parkinson's disease	1.3e-05	7.36e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTP1—Parkinson's disease	1.29e-05	7.33e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTP1—Parkinson's disease	1.29e-05	7.33e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—MAOA—Parkinson's disease	1.29e-05	7.31e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MAOA—Parkinson's disease	1.29e-05	7.31e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	1.28e-05	7.26e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	1.28e-05	7.25e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—HMOX1—Parkinson's disease	1.27e-05	7.23e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—HMOX1—Parkinson's disease	1.27e-05	7.23e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.27e-05	7.22e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTM1—Parkinson's disease	1.27e-05	7.21e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTM1—Parkinson's disease	1.27e-05	7.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—COMT—Parkinson's disease	1.27e-05	7.19e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	7.18e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	1.26e-05	7.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	1.26e-05	7.14e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	1.25e-05	7.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	1.24e-05	7.06e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CTGF—Parkinson's disease	1.24e-05	7.04e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCB1—Parkinson's disease	1.22e-05	6.94e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—Parkinson's disease	1.22e-05	6.94e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GPX1—Parkinson's disease	1.22e-05	6.91e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—GPX1—Parkinson's disease	1.22e-05	6.91e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP2D6—Parkinson's disease	1.21e-05	6.88e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.21e-05	6.88e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—COMT—Parkinson's disease	1.2e-05	6.82e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTP1—Parkinson's disease	1.2e-05	6.79e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—MAOA—Parkinson's disease	1.19e-05	6.77e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CTGF—Parkinson's disease	1.19e-05	6.75e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTM1—Parkinson's disease	1.19e-05	6.73e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTM1—Parkinson's disease	1.19e-05	6.73e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—HMOX1—Parkinson's disease	1.18e-05	6.69e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.16e-05	6.6e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	6.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	1.16e-05	6.58e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP2E1—Parkinson's disease	1.16e-05	6.56e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NQO1—Parkinson's disease	1.14e-05	6.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	1.14e-05	6.49e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CTGF—Parkinson's disease	1.14e-05	6.47e-05	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.14e-05	6.45e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GPX1—Parkinson's disease	1.14e-05	6.45e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—GPX1—Parkinson's disease	1.14e-05	6.45e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—Parkinson's disease	1.13e-05	6.43e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—TH—Parkinson's disease	1.13e-05	6.4e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—MTHFR—Parkinson's disease	1.12e-05	6.37e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—Parkinson's disease	1.12e-05	6.37e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP2E1—Parkinson's disease	1.11e-05	6.29e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.11e-05	6.28e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTM1—Parkinson's disease	1.1e-05	6.24e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NQO1—Parkinson's disease	1.1e-05	6.22e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYCS—Parkinson's disease	1.08e-05	6.14e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—TH—Parkinson's disease	1.08e-05	6.13e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	6.03e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.06e-05	6.02e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.06e-05	6.01e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—GPX1—Parkinson's disease	1.05e-05	5.97e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NQO1—Parkinson's disease	1.05e-05	5.97e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—Parkinson's disease	1.05e-05	5.95e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—Parkinson's disease	1.05e-05	5.95e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—Parkinson's disease	1.04e-05	5.93e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—Parkinson's disease	1.04e-05	5.93e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYCS—Parkinson's disease	1.04e-05	5.89e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—TH—Parkinson's disease	1.04e-05	5.88e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—INS—Parkinson's disease	1.03e-05	5.87e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2D6—Parkinson's disease	1.02e-05	5.8e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.02e-05	5.77e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.01e-05	5.74e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	1.01e-05	5.71e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CTGF—Parkinson's disease	1e-05	5.69e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYCS—Parkinson's disease	9.94e-06	5.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.91e-06	5.63e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—Parkinson's disease	9.75e-06	5.54e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—Parkinson's disease	9.75e-06	5.54e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—Parkinson's disease	9.71e-06	5.51e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	9.7e-06	5.51e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—COMT—Parkinson's disease	9.58e-06	5.44e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTP1—Parkinson's disease	9.53e-06	5.41e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—MAOA—Parkinson's disease	9.51e-06	5.4e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—HMOX1—Parkinson's disease	9.4e-06	5.34e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2E1—Parkinson's disease	9.34e-06	5.3e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	9.28e-06	5.27e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NQO1—Parkinson's disease	9.23e-06	5.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.19e-06	5.22e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—COMT—Parkinson's disease	9.18e-06	5.21e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—Parkinson's disease	9.14e-06	5.19e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—MAOA—Parkinson's disease	9.12e-06	5.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—TH—Parkinson's disease	9.1e-06	5.17e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.07e-06	5.15e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—Parkinson's disease	9.04e-06	5.13e-05	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—Parkinson's disease	9.02e-06	5.12e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—Parkinson's disease	9.02e-06	5.12e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—HMOX1—Parkinson's disease	9.01e-06	5.12e-05	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—Parkinson's disease	9.01e-06	5.12e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—INS—Parkinson's disease	8.93e-06	5.07e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—INS—Parkinson's disease	8.93e-06	5.07e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.83e-06	5.02e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—COMT—Parkinson's disease	8.8e-06	5e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—Parkinson's disease	8.76e-06	4.98e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—Parkinson's disease	8.76e-06	4.97e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—MAOA—Parkinson's disease	8.74e-06	4.96e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYCS—Parkinson's disease	8.74e-06	4.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.72e-06	4.95e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—Parkinson's disease	8.65e-06	4.91e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—Parkinson's disease	8.64e-06	4.91e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.48e-06	4.82e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—Parkinson's disease	8.4e-06	4.77e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPX1—Parkinson's disease	8.39e-06	4.76e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—INS—Parkinson's disease	8.33e-06	4.73e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—INS—Parkinson's disease	8.33e-06	4.73e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—Parkinson's disease	8.29e-06	4.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MCCC1—Parkinson's disease	8.21e-06	4.67e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ND3—Parkinson's disease	8.21e-06	4.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—Parkinson's disease	8.05e-06	4.57e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPX1—Parkinson's disease	8.04e-06	4.57e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—Parkinson's disease	7.96e-06	4.52e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—Parkinson's disease	7.74e-06	4.4e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—COMT—Parkinson's disease	7.74e-06	4.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TALDO1—Parkinson's disease	7.72e-06	4.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—OMD—Parkinson's disease	7.72e-06	4.39e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—INS—Parkinson's disease	7.72e-06	4.38e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPX1—Parkinson's disease	7.71e-06	4.38e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—Parkinson's disease	7.7e-06	4.37e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MAOA—Parkinson's disease	7.68e-06	4.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.62e-06	4.33e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—Parkinson's disease	7.6e-06	4.31e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.58e-06	4.31e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.56e-06	4.3e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.51e-06	4.27e-05	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.49e-06	4.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.48e-06	4.25e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—Parkinson's disease	7.42e-06	4.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	7.32e-06	4.16e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—Parkinson's disease	7.29e-06	4.14e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—Parkinson's disease	7.21e-06	4.09e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—Parkinson's disease	7.11e-06	4.04e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—Parkinson's disease	7.08e-06	4.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCH1—Parkinson's disease	6.98e-06	3.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.97e-06	3.96e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—Parkinson's disease	6.91e-06	3.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.87e-06	3.9e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—Parkinson's disease	6.78e-06	3.85e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—Parkinson's disease	6.62e-06	3.76e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—Parkinson's disease	6.43e-06	3.65e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—Parkinson's disease	6.33e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.3e-06	3.58e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—Parkinson's disease	6.25e-06	3.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GBA—Parkinson's disease	6.23e-06	3.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FBP1—Parkinson's disease	6.23e-06	3.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DBH—Parkinson's disease	6.23e-06	3.54e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—INS—Parkinson's disease	6.16e-06	3.5e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—INS—Parkinson's disease	5.9e-06	3.35e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—Parkinson's disease	5.82e-06	3.31e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—INS—Parkinson's disease	5.66e-06	3.21e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—Parkinson's disease	5.6e-06	3.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—INS—Parkinson's disease	4.97e-06	2.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ND3—Parkinson's disease	4.94e-06	2.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.94e-06	2.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—OMD—Parkinson's disease	4.64e-06	2.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.64e-06	2.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DDC—Parkinson's disease	4.57e-06	2.6e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—Parkinson's disease	4.52e-06	2.57e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.4e-06	2.5e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.31e-06	2.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.26e-06	2.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.2e-06	2.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.89e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.85e-06	2.18e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GBA—Parkinson's disease	3.74e-06	2.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.74e-06	2.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DBH—Parkinson's disease	3.74e-06	2.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.66e-06	2.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.86e-06	1.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.81e-06	1.59e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DDC—Parkinson's disease	2.75e-06	1.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.61e-06	1.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.59e-06	1.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.58e-06	1.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TH—Parkinson's disease	2.55e-06	1.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.45e-06	1.39e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.34e-06	1.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.31e-06	1.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COMT—Parkinson's disease	2.17e-06	1.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.16e-06	1.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.15e-06	1.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.13e-06	1.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.04e-06	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.98e-06	1.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.9e-06	1.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.75e-06	9.94e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.72e-06	9.76e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.69e-06	9.58e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—Parkinson's disease	1.63e-06	9.26e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.57e-06	8.93e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.55e-06	8.83e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TH—Parkinson's disease	1.53e-06	8.7e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.47e-06	8.35e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—INS—Parkinson's disease	1.39e-06	7.91e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COMT—Parkinson's disease	1.3e-06	7.4e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.3e-06	7.36e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.29e-06	7.35e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.28e-06	7.26e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.23e-06	6.97e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.19e-06	6.77e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.14e-06	6.48e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.05e-06	5.98e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—Parkinson's disease	9.8e-07	5.57e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—INS—Parkinson's disease	8.37e-07	4.76e-06	CbGpPWpGaD
